Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc. (CMRA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CMRA · as of Sep 30, 2023
Ownership Breakdown
13
Institutional Holders
▲ 3 vs Q2
$194,097
Total Inst. Value
▲ $90,936 vs Q2
30.74M
Shares Outstanding
freeFloat 44.01%
724,657
13F Shares Held
▲ 512,548 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CMRA largest shareholders · institutional ownership
Q3 2023 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
CI PRIVATE WEALTH, LLC pharmaceutical preparations | 493.7K | 2.58% | 2.58% | $123.42M | Nov 3, 2023 | NEW |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 70.2K | 36.66% | 36.66% | $22.40M | Nov 13, 2023 | ▲ 10.2K |
HIGHTOWER ADVISORS, LLC pharmaceutical preparations | 47.6K | 24.85% | 24.85% | $14.00M | Nov 8, 2023 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 44.1K | 23.02% | 23.02% | $12.86M | Dec 18, 2023 | — held |
STATE STREET CORP pharmaceutical preparations | 29.6K | 15.45% | 15.45% | $9.44M | Nov 14, 2023 | — held |
CITADEL ADVISORS LLC pharmaceutical preparations | 17.5K | 9.11% | 9.11% | $5.57M | Nov 14, 2023 | NEW |
UBS GROUP AG pharmaceutical preparations | 8.0K | 4.19% | 4.19% | $2.33M | Nov 9, 2023 | ▲ 6.4K |
TOWER RESEARCH CAPITAL LLC (TRC) pharmaceutical preparations | 7.3K | 3.83% | 3.83% | $2.14M | Nov 14, 2023 | ▼ 24 |
ADVISOR GROUP HOLDINGS, INC. pharmaceutical preparations | 3.6K | 1.88% | 1.88% | $1.05M | Nov 13, 2023 | ▼ 15.2K |
MORGAN STANLEY pharmaceutical preparations | 2.3K | 1.20% | 1.20% | $668,000 | Nov 15, 2023 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2023 vs prior quarter
Q3 2023
2
Increased
+16.6K shares3
New Positions
first time holders3
Decreased
−15.2K shares0
Sold Out
fully exitedNet shares change (top 50)
+1.4K
+16.6K / −15.2K
Net new holders
+2
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CMRA insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
7
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Konar Shameek Member of 10% owner group | Dec 29, 2023 | Purchase | 4,090,908 | $0.06 | $225.0K | 4.09M | Form 4 ↗ |
Konar Shameek Member of 10% owner group | Dec 29, 2023 | Purchase | 0 | $0.06 | $0 | 0 | Form 4 ↗ |
DENNY GEORGE P III | Dec 29, 2023 | Purchase | 3,913,526 | $0.06 | $215.2K | 3.91M | Form 4 ↗ |
DENNY GEORGE P III | Dec 29, 2023 | Purchase | 0 | $0.06 | $0 | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Comera Life Sciences Holdings, Inc. (CMRA) is primarily owned by institutional investors, who hold approximately 2.4% of total shares outstanding. Company insiders own approximately 55.99%, while retail and public investors account for the remaining 41.65%.
The largest institutional shareholder of Comera Life Sciences Holdings, Inc. is CI PRIVATE WEALTH, LLC, holding approximately 493,692 shares — equal to 2.58% of outstanding shares — as of September 30, 2023.
A total of 13 institutional investors currently hold CMRA stock, with a combined institutional value of approximately $194,097 as of the most recent 13F filing period.
Frequently asked questions
CMRA ownershipComera Life Sciences Holdings, Inc. (CMRA) is primarily owned by institutional investors, who hold approximately 2.4% of shares. The largest shareholder is CI PRIVATE WEALTH, LLC with a 2.58% stake. Company insiders hold 55.99%. Data sourced from SEC Form 13F as of September 30, 2023.